NIP
PGEN icon

Nicholas Investment Partners’s Precigen PGEN Stock Holding History

Nicholas Investment Partners’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-40,689
Closed -$1.07M – 333
2014
Q4 		$1.07M Buy
+40,689
New +$892K 0.07% 286

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nicholas Investment Partners's PGEN Position: Q1 2015 in Review

Nicholas Investment Partners sold out of Precigen (PGEN) in Q1 2015, closing a stake of 40,689 shares — an estimated $1.07M sold.

Nicholas Investment Partners first reported a position in PGEN in Q4 2014 and held it in 1 quarter. The position peaked at $1.07M in Q4 2014. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2015.

  • Nicholas Investment Partners reported no remaining Precigen position as of Q1 2015 after selling out during the quarter.
  • Nicholas Investment Partners sold 40,689 Precigen shares in Q1 2015, an estimated $1.07M.
  • Nicholas Investment Partners first reported a position in Precigen in Q4 2014 and held it in 1 quarter.
  • Nicholas Investment Partners's Precigen position peaked at $1.07M in Q4 2014.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2015.

Based on Nicholas Investment Partners's 13F filing for Q1 2015, filed 15 May 2015.